Business Description
![Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C00000PDU.png?14)
Madrigal Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US5588681057
Description
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.27 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -13 | |||||
3-Year EPS without NRI Growth Rate | -15.2 | |||||
3-Year FCF Growth Rate | -19.5 | |||||
3-Year Book Growth Rate | 9.6 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.01 | |||||
9-Day RSI | 53.65 | |||||
14-Day RSI | 54.91 | |||||
6-1 Month Momentum % | 21.86 | |||||
12-1 Month Momentum % | 36.76 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.39 | |||||
Quick Ratio | 9.39 | |||||
Cash Ratio | 9.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.6 | |||||
Shareholder Yield % | -10.37 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -145 | |||||
ROA % | -85.58 | |||||
ROIC % | -2861.19 | |||||
ROC (Joel Greenblatt) % | -19337.28 | |||||
ROCE % | -104.13 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 6.92 | |||||
Price-to-Tangible-Book | 6.95 | |||||
EV-to-EBIT | -11.85 | |||||
EV-to-Forward-EBIT | -7.73 | |||||
EV-to-EBITDA | -11.87 | |||||
EV-to-Forward-EBITDA | -7.74 | |||||
EV-to-Forward-Revenue | 64.11 | |||||
EV-to-FCF | -13.03 | |||||
Price-to-Net-Current-Asset-Value | 6.98 | |||||
Price-to-Net-Cash | 7.11 | |||||
Earnings Yield (Greenblatt) % | -8.44 | |||||
FCF Yield % | -6.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MDGL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Madrigal Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -23.13 | ||
Beta | -1.2 | ||
Volatility % | 75.4 | ||
14-Day RSI | 54.91 | ||
14-Day ATR ($) | 12.773104 | ||
20-Day SMA ($) | 281.5365 | ||
12-1 Month Momentum % | 36.76 | ||
52-Week Range ($) | 119.7604 - 299.98 | ||
Shares Outstanding (Mil) | 21.31 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Madrigal Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Madrigal Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Madrigal Pharmaceuticals Inc Frequently Asked Questions
What is Madrigal Pharmaceuticals Inc(MDGL)'s stock price today?
The current price of MDGL is $284.35. The 52 week high of MDGL is $299.98 and 52 week low is $119.76.
When is next earnings date of Madrigal Pharmaceuticals Inc(MDGL)?
The next earnings date of Madrigal Pharmaceuticals Inc(MDGL) is 2024-08-07.
Does Madrigal Pharmaceuticals Inc(MDGL) pay dividends? If so, how much?
Madrigal Pharmaceuticals Inc(MDGL) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |